The company collected capital from 11 investors. It develops endoscopy devices designed to enable minimally invasive surgical procedures, according to the report.
More Articles on Supply Chain:
MiMedx Group Supports CMS’s New Skin Substitute Reimbursement Methodology
Amerinet, Richard Wolf Enter Into Endoscopic Products Partnership
Janssen Therapeutics’ OLYSIO Inhibitor Receives FDA Approval for Hepatitis C Treatments
